VOYA Investment Management
AVTX icon

VOYA Investment Management’s Avalo Therapeutics AVTX Stock Holding History

VOYA Investment Management’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7
Closed -$34K – 2657
2021
Q4 		$34K Sell
7
-1
-13% -$6K ﹤0.01% 2766
2021
Q3 		$48K Hold
8
– – ﹤0.01% 2802
2021
Q2 		$71K Buy
8
+2
+33% +$16.8K ﹤0.01% 2800
2021
Q1 		$56K Buy
+6
New +$56.7K ﹤0.01% 2736
2020
Q2 		– Sell
-5
Closed -$32K – 2513
2020
Q1 		$32K Hold
5
– – ﹤0.01% 2554
2019
Q4 		$70K Buy
5
+1
+25% +$10.5K ﹤0.01% 2609
2019
Q3 		$39K Hold
4
– – ﹤0.01% 2526
2019
Q2 		$65K Buy
+4
New +$60.6K ﹤0.01% 2535

Other funds holding AVTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

VOYA Investment Management's AVTX Position: Q1 2022 in Review

VOYA Investment Management sold out of Avalo Therapeutics (AVTX) in Q1 2022, closing a stake of 7 shares — an estimated $34K sold.

VOYA Investment Management first reported a position in AVTX in Q2 2019 and held it in 8 quarters. The position peaked at $71K in Q2 2021. 65 funds tracked by Wall St. Rank hold AVTX as of Q1 2022.

  • VOYA Investment Management reported no remaining Avalo Therapeutics position as of Q1 2022 after selling out during the quarter.
  • VOYA Investment Management sold 7 Avalo Therapeutics shares in Q1 2022, an estimated $34K.
  • VOYA Investment Management first reported a position in Avalo Therapeutics in Q2 2019 and held it in 8 quarters.
  • VOYA Investment Management's Avalo Therapeutics position peaked at $71K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q1 2022.

Based on VOYA Investment Management's 13F filing for Q1 2022, filed 16 May 2022.